You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK – OpGen reported Tuesday preliminary first quarter 2020 revenues of $617,000, down 38 percent from $1 million in the first quarter of 2019.
OpGen's first quarter revenues exclude revenue from Curetis, which it acquired on April 1.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.